We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan
Price data last checked 122 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 8 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 127 days • 127 data points (No recent data available)
Price Distribution
Price distribution over 127 days • 1 price levels
Price Analysis
Most common price: £495 (127 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 127 days
Product Specifications
- Format
- Paperback
- ASIN
- B0BP9S1JMF
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 28 November 2022
- Listed Since
- 08 December 2022
Similar Products You Might Like
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
The 2016-2021 Outlook for Cancer Therapies in Asia
The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
The 2023-2028 Outlook for Cancer Vaccines in Japan
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
The 2025-2030 World Outlook for Immune-Oncology Treatments
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
The 2025-2030 World Outlook for Immuno Oncology Assays
The 2016-2021 Outlook for Cancer Therapies in Oceana
